Key result
The definition of resistant hypertension and its consequences for special treatments, such as renal denervation and baroreceptor activating therapy, are discussed in this review.
This review highlights the need to critically evaluate the definition of resistant hypertension to avoid unnecessary and expensive treatments like renal denervation.
Answers are grounded in this paper and cite their sources.
Clinicians should verify resistant hypertension criteria before device therapies; leaves open standardized definitions for prospective trials.
Resistant hypertension (RH) was defined many years ago as a clinical situation in which blood pressure remains uncontrolled despite concomitant intake of at least three antihypertensive drugs (one of them preferably being a diuretic) at full doses. This operative definition was aimed at identifying a subset of hypertensive patients requiring a more extensive clinical workup in order to achieve an adequate blood pressure control. An oversimplification of this picture led to consider RH as a separate clinical entity requiring special, expensive treatments, such as renal denervation and baroreceptor activating therapy. In this review we will discuss the utility and the shortcomings of the definition of RH and the possible consequences for treatment.
No takes yet. Share an insight, caveat, or question.
Taddei et al. (2016) conducted a review in Resistant hypertension. Special treatments (e.g., renal denervation, baroreceptor activating therapy) was evaluated. The definition of resistant hypertension and its consequences for special treatments, such as renal denervation and baroreceptor activating therapy, are discussed in this review.
Synapse has enriched 10 related papers. Consider them for comparative context: